A standardized protocol for the evaluation of hand disinfection by surgical scrub formulations was applied to volunteers in a multicenter trial. Povidone iodine (PVI), chlorhexidine (CHX), and a nonmedicated soap (NMS) were tested. The scrubbing procedure involved three daily hand washings for five consecutive days; surviving bacteria were counted daily after being collected in a suitable neutralizing solution. Immediate efficacy (IE), cumulative efficacy (CE), and remanent effect (RE) were calculated by reference to the control hand. Statistical analyses of IE, CE, and RE showed significant differences among the three scrub formulations. IEs of PVI and CHX were equivalent and different from IE of NMS; CE and RE of CHX were higher than those of PVI and NMS. On the basis of the statistical analysis, the population size required for further studies aimed at detecting significant differences between surgical scrub formulations could be estimated.
Standardized methods for the evaluation of the bactericidal activities of antiseptics are available in several countries as guidelines (O.T.C. [15] and the Association of Official Analytical Chemists [3] in the United States, Deutsche Gesellschaft fur Hygiene und Mikrobiologie [10] in the Federal Republic of Germany) or as official methods (Pharmacopeia [12] and Association Franqaise de Normalisation [2] in France). The situation is different for methods of testing surgical hand disinfection. A review of the literature (13, 14, 17, 19) shows that the protocols differ on several points: nature of bacteria (normal or artificial flora), recovery of bacteria (fingerprint, hand bathing, glove washing, etc.), choice of the reference value (base-line counts, control counts, etc.), and expression of results (comparison with a reference preparation, rate of reduction of flora, etc.). The discordances in results for a given scrub formulation are not surprising and may be attributed to the diversity of the methodologies. Moreover, the mode of application of the antiseptic is an important factor in its activity, and standardization is difficult to achieve.
Since 1976, the French Society of Microbiology has attempted to define standardized methods for the evaluation of antiseptics in vivo. The first step was a protocol for the evaluation of the immediate efficacy (IE) after a single application (5) . The hand-washing procedure and the mode of bacteria recovery and count were pointed out as the most important causes of discrepancies.
Here, we report the results obtained in a multicenter trial in which two surgical scrub formulations (considered as the most effective among those available in France) and a nonmedicated soap (NMS) (as a control) were applied to volunteers three times a day for five consecutive days. No preliminary selection of volunteers nor any pretreatment of the hands was performed. The 10, 6, 8, 6, 10, 6 , and 3 subjects, respectively), while one center was missing for the NMS study (41 subjects, six groups of 10, 6, 7, 6, 6, and 6 subjects, respectively) and two centers were missing for the CHX study (35 subjects, five groups of 10, 6, 8, 8 , and 3 subjects, respectively). All subjects were instructed to avoid the use of antiseptics, detergents, and gloves during the experiment.
Scrub formulations and scrubbing procedure. PVI (10%; Betadine Scrub, SARGET Laboratories) and chlorhexidine digluconate (4%; Hibiscrub, ICI-PHARMA) were retained as antiseptic formulations. The NMS was prepared according to the formula of the French Pharmacopeia (11) .
The protocol involved two (day 1 and day 5) or three (day 2 to day 4) daily hand washings (at 3.5-to 4-h intervals) for five consecutive days and a single washing on day 8 ( Table  1 ). Recovery of bacteria was performed at the same time every day for each subject (12 a.m. to 2 p.m.) before (control hand = left hand) and after (test hand = right hand) the first washing (day 1), the second washing (day 2 to day 5), and the last washing (day 8).
The scrubbing procedure was performed under supervision on wet hands. It involved two successive applications of scrub formulation or soap (5 ml) on both hands. The first application (1 min) was nail brushing, followed by rinsing with running tap water. The second application was scrubbing of the whole of both hands for 3 min with particular attention to the interdigital spaces. This was followed by a first rinsing with tap water and a second with sterile distilled water (500 ml). Hands were dried with sterile compresses or paper towels. Collection and count of bacteria. Hand flora was recovered in a sterile plastic bag containing 400 ml of a neutralizing solution (Tween 80 [3%, wt/vol], Triton X-100 [0.1%, wt/ vol], sodium thioglycolate [0.2%, wt/vol], sodium thiosulfate [0.3%, wt/vol], in 0.066 M phosphate buffer, pH 7.9) which has previously been demonstrated as convenient for the two scrub formulations and the soap (16) . Five minutes after the end of the scrubbing procedure (and just before for the control), the appropriate hand was plunged into the bag and agitated for 5 min. The solution was then transferred into a sterile bottle. Samples (1-ml undiluted and 1 ml of 10-1 and 10-2 serial dilutions) were placed in 15 Table 2 for one group. For all the groups, it was obvious that the most representative results of efficacy was IE on day 1 (5 min after the first application), CE on day 5 and RE on day 5, and RE on day 8 (after 3 days of interruption). Consequently, statistical analysis was limited to these results.
As the groups were highly disparate (number and age range of the subjects, geographic dispersion, and period of testing), the differences in variances and in means were tested first. For the variances, results shown in Table 3 were considered as satisfactory except for IE on day 1 and PVI (P = 0.013) and CE on day 5 and CHX (P = 0.024). Despite these anomalies, no significant differences were noted between the experimental means obtained for PVI and CHX in all groups on day 1 and day 5. For NMS and RE on day 5, mean values differed significantly. For RE on day 8, reversed results were observed: means were homogeneous for NMS (no RE) and significantly different for the two antiseptics; this fact may be imputed to the reconstitution of the normal flora, which probably differed among subjects and groups.
To compare the efficacy of the antiseptics with each other and with the NMS, we considered all the experimental results. The mean log reduction values are reported in Table  4 , as are the results of Student's t test.
(i) After a single application, there was no significant difference between PVI and CHX (IE on day 1, 0.94 and 1.08, respectively), but both were significantly different from NMS (0.62; P < 0.01).
(ii) Following a continual application, a highly significant difference (P = 0.000) was observed for CE on day 5 between PVI (1.67) and CHX (2.42), both being significantly more effective than NMS (0.78; P = 0.000). Since PVI and CHX could not be differentiated by their IE, the RE on day 5 determined on the control hand (CHX, 1.33; PVI, 0.99; NMS, 0.39) was considered as the main factor involved. The persistence of the antibacterial activity of CHX was confirmed 72 h after the last scrubbing (RE on day 8 = 0.45), 5. whereas under the same conditions, no reduction in hand flora was observed for NMS (0.06) or PVI (0.20), whose effects could not be differentiated (P = 0.281).
The efficacy of the scrubbing procedure was estimated by reference to the control count on day 1 (Cl), and the value of this base-line count may interfere with the results. As no preliminary selection of subjects was done, we sought to determine whether a high control count led to a higher bacterial reduction and therefore to a higher efficacy; a statistical analysis was performed after the subjects were partitioned into two subgroups (Cl . 6.5 and Cl > 6.5), and IE on day 1 and CE on day 5 were calculated ( Table 5 ). The scrubbing procedure performed with NMS gave similar results whatever the initial level of hand flora; no change occurred in ranking of the three scrub formulations: NMS < PVI < CHX. With PVI, both criteria of -efficacy significantly depended on the value of Cl. With CHX, no difference was observed after a single application (IE on day 1), but results obtained on day 5 were significantly different.
In studies focused on the comparison of antiseptics, the optimal number of subjects required for a reliable evaluation of the efficacies must be determined. Using a bilateral Student's t test, we calculated the population size needed to demonstrate a difference of efficacy between two scrub formulations (Table 6 ). For IE on day 1, a small number of subjects (10 to 15) is needed to differentiate an antiseptic scrub formulation from an NMS, and 35 subjects would suffice to differentiate between two antiseptics (difference of efficacy = 0.4). About 140 subjects, however, would be required to compare two antiseptics the efficacy of which differs by 0.2. On the basis of cumulative efficacy results, (20), most of the results reported in the literature (1, 8, 19) showed no significant difference in counts between the left hand and the right hand. As our preliminary work (18) agreed with this observation, each hand was appointed a fixed function in the standardized protocol.
The efficacy of PVI and CHX has been reported in several studies (4, 7, 9, 19) . In particular, the RE of formulations including CHX salts has been demonstrated in vivo (4, 6, 9) . For both antiseptics, the results reported in Table 2 showed a permanent reduction (RE = 1 to 1.5) of the control hand flora, which, for CHX only, was maintained even after the applications were stopped. Although the antibacterial activity of iodine is probably limited in time, it may be thought that the RE observed during the five successive days of application is imputable to the bactericidal effect, which reduces the bacterial population and perhaps its growth rate.
A continual scrubbing protocol with an NMS reduced the hand flora (NMS CE on day 5 In conclusion, the protocol described may be considered as satisfactory for the comparison of scrub formulations since it allows sorting between ineffective, bactericidal, and bactericidal plus remanent scrubs. Its main characteristics are no preliminary selection of subjects in function of their base-line flora; the possibility of partitioning the subjects into groups varying in place or time; and simultaneous study of different criteria of efficacy (IE, CE, and RE). These conditions reduce the cost of such studies given that the population size may be limited in function of the objectives.
